AzTrials
AzTrials

DeliriumNCT07536854

Early Delirium Prediction Via Serial EEG Trajectories and Machine Learning

An observational study of Delirium and Trauma, run by Ajou University School of Medicine at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to develop a machine learning model that can predict delirium in trauma patients before it clinically appears. The study focuses on analyzing brainwave (EEG) patterns collected over several days in the trauma ICU. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Delirium, Trauma, Brain Dysfunction
How many people
73 participants
Where
1 siteSouth Korea
Study dates
1 Apr 2024to 30 Apr 2025
How long will I take part?
3 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult trauma patients (aged 18-65) admitted to the Trauma Intensive Care Unit (TICU) at a level 1 trauma center in Korea. The cohort includes critically ill patients with a record of severe injury (ISS≥ 9) who are able to undergo serial EEG monitoring and clinical delirium assessments. Patients with pre-existing neurological or psychiatric disorders, or those with severe traumatic brain injury (AIS ≥ 2), are excluded to ensure the specificity of the neurophysiologic data.

  1. Inclusion Criteria: Trauma patients admitted to the Trauma Intensive Care Unit (TICU) who meet the following criteria:
  • Patients aged 18 to 65 years.
  • Severe trauma patients with an Injury Severity Score (ISS)
  1. Exclusion Criteria:

Patients with a head Abbreviated Injury Scale (AIS) ≥ 2 Patients with a Richmond Agitation-Sedation Scale (RASS) score ≤ -2 History of neurological disorders (e.g., Parkinson's disease, dementia, cerebrovascular disease) History of major psychiatric disorders (e.g., schizophrenia, bipolar disorder, intellectual disability, autism spectrum disorder) History of illicit drug use disorder or positive results on a urine drug screen for substances other than Benzodiazepines or Tricyclic antidepressants.

Clinical evidence of acute alcohol withdrawal (CIWA-Ar score > 10) History of liver failure or hepatic encephalopathy (Child-Pugh Class B or C) Renal impairment requiring renal replacement therapy (RRT) Inability to perform the Confusion Assessment Method for the ICU (CAM-ICU) due to the following Inability to communicate in Korean Failure to obey commands (unable to follow test instructions) Severe visual or hearing impairment Refusal to undergo CAM-ICU assessment Requirement for isolation due to infectious diseases (e.g., COVID-19, active tuberculosis).

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Ajou University Hospital

    Suwon, Kyonggi-do, 16499

Other trials in South Korea

About this study

Official title: Longitudinal Frontal EEG Trajectories Reveal Divergent Cortical Dynamics in Delirium After Severe Trauma

The goal of this observational study is to develop a machine learning model that can predict delirium in trauma patients before it clinically appears. The study focuses on analyzing brainwave (EEG) patterns collected over several days in the trauma ICU. By comparing different recording conditions-such as having eyes open versus closed-researchers aim to identify the most effective way to monitor brain health and detect early signs of delirium in critically ill patients.

Read the detailed description

Background and Rationale:

Delirium is a critical manifestation of acute brain dysfunction, affecting 10-15% of all hospitalized patients and over 25% of those in intensive care units (ICU). In the trauma ICU, patients are particularly vulnerable due to an inflammatory cascade from repeated surgeries, blood-brain barrier disruption, traumatic brain injury (TBI), and mandatory opioid administration. Despite its clinical significance-including increased mortality and long-term cognitive impairment-early detection remains challenging. Current bedside tools like the CAM-ICU are limited by their periodic nature and dependence on clinician expertise, often missing the rapid neurophysiologic fluctuations that define delirium.

Study Objectives and Methodology:

While previous studies have used electroencephalography (EEG) as a "snapshot" to identify delirium, such cross-sectional approaches often reflect transient sedative depth rather than true neurocognitive vulnerability. This study proposes a longitudinal approach, focusing on the trajectory of change in cortical dynamics over time.

We acquired brief, serial resting-state EEG three times daily for at least three consecutive days from critically ill trauma patients. Using a feasible frontal montage, we quantified a comprehensive set of features, including spectral power (slowing), nonlinear complexity, and phase-based functional connectivity.

Research Hypothesis:

The framework utilizes machine learning (ML) to harness these longitudinal trajectories, aiming to predict delirium vulnerability before formal clinical diagnosis. Furthermore, we hypothesize that eyes-open recordings-by imposing a minimal arousal constraint-will better capture wakeful network integrity and provide superior predictive power compared to traditional eyes-closed recordings, which are often confounded by sedation and drowsiness in the trauma ICU environment.

Clinical Impact:

By identifying the optimal recording condition and establishing an ML-based prediction framework, this study seeks to define a standardized neurophysiologic monitoring strategy. This will ultimately facilitate early intervention and improve the long-term neurological prognosis of severe trauma survivors.

Keywords
delirium, EEG, machine learning, Delirium prediction
Medical subject headings
Delirium, Wounds and Injuries, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07536854
Study groupRoleWhat they receive
Delirum groupPatients who developed delirium during their ICU stay (confirmed by CAM-ICU)
Non-Delirium GroupPatients who did not develop delirium during their ICU stay.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Predictive Performance for Delirium (Area Under the Receiver Operating Characteristic Curve, AUROC

    The predictive accuracy of the machine learning model based on longitudinal EEG trajectories will be evaluated to identify patients at risk of delirium. Model performance will be assessed using AUROC, sensitivity, specificity, and F1-score.

    Measured: 3 to 4 days (during the longitudinal EEG data collection period)

Secondary outcomes (1)
  1. Comparison of Model Performance: Eyes-Open vs. Eyes-Closed States

    Comparison of the area under the receiver operating characteristic curve (AUROC) between EEG data recorded during eyes-open and eyes-closed resting states to determine which condition provides superior predictive power.

    Measured: 3 to 4 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2026
  2. Study start1 Apr 2024
  3. Primary completion27 Apr 2025
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
73 participants (actual)
Target duration
3 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07536854
Sponsor's protocol ID
AJOUIRB-IV-2024-227
Status last verified
Apr 2026
First submitted
12 Apr 2026
Last updated
17 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to institutional policies regarding data privacy and the protection of sensitive patient information.

Publications

  • Sun H, Kimchi E, Akeju O, Nagaraj SB, McClain LM, Zhou DW, Boyle E, Zheng WL, Ge W, Westover MB. Automated tracking of level of consciousness and delirium in critical illness using deep learning. NPJ Digit Med. 2019 Sep 9;2:89. doi: 10.1038/s41746-019-0167-0. eCollection 2019.

    PubMed 31508499
  • Numan T, van den Boogaard M, Kamper AM, Rood PJT, Peelen LM, Slooter AJC; Dutch Delirium Detection Study Group. Delirium detection using relative delta power based on 1-minute single-channel EEG: a multicentre study. Br J Anaesth. 2019 Jan;122(1):60-68. doi: 10.1016/j.bja.2018.08.021. Epub 2018 Oct 2.

    PubMed 30579407
  • Kim H, McKinney A, Brooks J, Mashour GA, Lee U, Vlisides PE. Delirium, Caffeine, and Perioperative Cortical Dynamics. Front Hum Neurosci. 2021 Dec 20;15:744054. doi: 10.3389/fnhum.2021.744054. eCollection 2021.

    PubMed 34987367
  • Hshieh TT, Saczynski J, Gou RY, Marcantonio E, Jones RN, Schmitt E, Cooper Z, Ayres D, Wright J, Travison TG, Inouye SK; SAGES Study Group. Trajectory of Functional Recovery After Postoperative Delirium in Elective Surgery. Ann Surg. 2017 Apr;265(4):647-653. doi: 10.1097/SLA.0000000000001952.

    PubMed 27501176
  • Bryczkowski SB, Lopreiato MC, Yonclas PP, Sacca JJ, Mosenthal AC. Risk factors for delirium in older trauma patients admitted to the surgical intensive care unit. J Trauma Acute Care Surg. 2014 Dec;77(6):944-51. doi: 10.1097/TA.0000000000000427.

    PubMed 25248058
  • Walder B, Haase U, Rundshagen I. [Sleep disturbances in critically ill patients]. Anaesthesist. 2007 Jan;56(1):7-17. doi: 10.1007/s00101-006-1086-4. German.

    PubMed 16953422

Questions about this trial

What is this clinical trial studying?

An observational study of Delirium and Trauma, run by Ajou University School of Medicine at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Predictive Performance for Delirium (Area Under the Receiver Operating Characteristic Curve, AUROC (time frame: 3 to 4 days (during the longitudinal EEG data collection period)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07536854, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in